Implantation of an Adjustable Suburethral Sling is an Effective Treatment Method for Patients With Mixed Urinary Incontinence of Moderate to Severe Severity, After Which the Severity of the Stress and Urgency Components is Reduced.

Optimizing the Management of Patients With Mixed Urinary Incontinence.

The aim of this clinical study is to optimize treatment outcomes in patients with mixed forms of urinary incontinence by implanting an adjustable suburethral sling and to determine factors influencing treatment effectiveness. The main questions it aims to answer are:

1. What is the effectiveness of an adjustable suburethral sling in patients with mixed urinary incontinence?
2. How do preoperative medications and other factors affect the effectiveness of adjustable suburethral sling implantation?
3. How does quality of life change in these patients after surgery? Participants will undergo implantation of an adjustable suburethral sling. Postoperatively, the effectiveness of the sling for mixed urinary incontinence will be assessed. Predictors of treatment effectiveness will also be identified.

Patients will be examined 24 hours after surgery, 2 months later, and 1 year later.

Inclusion Criteria:

• Women over 18 years of age.
• Mixed urinary incontinence (stress and urgency components, with the stress component being predominant or equal) of moderate to severe severity, confirmed by questionnaire data.
• Signed informed consent to participate in the study.

Exclusion Criteria:

• Isolated stress or urge urinary incontinence.
• Contraindications to diagnosis and treatment.
• Obstructive urination, large residual urine volume.
• Chronic pelvic pain syndrome.
• Pelvic organ prolapse (grade 2 or higher according to POP-Q).
• History of any suburethral sling implantation.
• History of surgical treatment for pelvic organ prolapse.
• Pregnancy.